hepatocellular carcinoma

AstraZeneca reports positive data from Phase III trial of Imfinzi
Clinical Trials Arena
Mon, 01/22/24 - 11:29 am
AstraZeneca
Imfinzi
clinical trials
hepatocellular carcinoma
AstraZeneca’s Imfinzi meets PFS primary endpoint in Phase III HCC trial
Clinical Trials Arena
Fri, 11/10/23 - 10:06 am
AstraZeneca
clinical trials
Imfinzi
hepatocellular carcinoma
Harbour reports results from HCC combo therapy trial
Clinical Trials Arena
Mon, 05/29/23 - 12:23 pm
Harbour BioMed
porustobart
HCC
hepatocellular carcinoma
clinlcal trials
Genentech reveals positive results from cancer combo therapy trial
Clinical Trials Arena
Mon, 04/17/23 - 11:24 am
Genentech
Tecentriq
Avastin
liver cancer
hepatocellular carcinoma
Medivir completes initial Phase Ib part of HCC therapy trial
Clinical Trials Arena
Tue, 02/21/23 - 10:05 am
Medvir
fostrox
Lenvima
hepatocellular carcinoma
clinical trials
BeiGene and Novartis Make Late-Stage Progress against Liver Cancer
BioSpace
Tue, 08/9/22 - 12:14 pm
Novartis
BeiGene
hepatocellular carcinoma
liver cancer
clinical trials
Omega Gets FDA Nod to Start First-Ever Epigenomic Controller Trial
BioSpace
Fri, 07/15/22 - 10:59 am
Omega Therapeutics
hepatocellular carcinoma
OTX-2002
epigenomic controllers
clinical trials
FDA bars the door — for now — against Merck’s star cancer drug after Roche beat them to the punch
Endpoints
Wed, 07/8/20 - 10:43 am
Merck
FDA
complete response letter
Keytruda
Eisaid
Lenvima
hepatocellular carcinoma
Roche
Bristol Myers Squibb snags new liver cancer nod for Opdivo-Yervoy combo
Fierce Pharma
Wed, 03/11/20 - 12:58 pm
Bristol-Myers Squibb
Opdivo
Yervoy
FDA
liver cancer
hepatocellular carcinoma
AstraZeneca’s Combination Treatment for HCC Snags Orphan Drug Designation
BioSpace
Mon, 01/20/20 - 10:16 pm
AstraZeneca
Imfinzi
orphan drugs
FDA
hepatocellular carcinoma
Lilly gets fifth use for Cyramza with FDA liver cancer nod
Pharmaforum
Mon, 05/13/19 - 10:07 am
Eli Lilly
Cyramza
FDA
liver cancer
hepatocellular carcinoma
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
CP Wire
Fri, 04/26/19 - 10:06 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
RNAi
RNAi Therapeutics Focused Sirnaomics Closes $47 Million Series C Round
Fri, 04/26/19 - 10:01 am
Sriaomics
STP705
cholangiocarcinoma
hepatocellular carcinoma
AZ begins liver cancer immunotherapy tie-up with AVEO
Pharmaforum
Thu, 12/13/18 - 10:29 am
AstraZeneca
Aveo Oncology
cancer immunotherapy
Imfinzi
Fotivda
hepatocellular carcinoma
Merck gets FDA okay for Keytruda as liver cancer therapy
Pharmaforum
Mon, 11/12/18 - 09:35 am
Merck
Keytruda
FDA
hepatocellular carcinoma
liver cancer
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
CP WIre
Fri, 09/21/18 - 10:02 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Exelixis and Ipsen Announce Positive CHMP Opinion for Cabometyx in Previously Treated Hepatocellular Carcinoma
Fri, 09/21/18 - 10:01 am
Exelixis
Ipsen
Cabometyx
hepatocellular carcinoma
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Wed, 09/5/18 - 09:25 am
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
CP WIre
Thu, 08/23/18 - 10:20 am
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
Thu, 08/23/18 - 10:09 am
Eisai
Merck
Lenvima
hepatocellular carcinoma

Pages